Circulating microRNAs as promising diagnostic biomarkers for pancreatic cancer: a systematic review

Jinru Xue,1,* Erna Jia,2,* Na Ren,1 Andrew Lindsay,3,4 Haixin Yu1,51Department of Thoracic Surgery, China-Japan Union Hospital of Jilin University, Changchun, People’s Republic of China; 2Department of Gastroenterology, China-Japan Union Hospital of Jilin University, Changchun, People’s Republic of China; 3Major Cancer Biology, German Cancer Research Center, Heidelberg, Germany; 4Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany; 5Medical Faculty Heidelberg, University of Heidelberg, Heidelberg, GermanyCorrespondence: Haixin YuDepartment of Thoracic Surgery, China-Japan Union Hospital of Jilin University, No. 126, Xiantai Avenue, Changchun 130033, People’s Republic of ChinaTel +86 1 507 232 4782Fax +86 4 318 499 5852Email 534266311qq.com*These authors contributed equally to this workAbstract: Pancreatic cancer (PC) is one of the most common forms of malignant tumors and causes of tumor-related death worldwide. The current prognosis of PC still remains poor due to the lack of effective early detection method. Recently, there is strong support that circulating miRNAs can be used as biomarkers for early detection of various cancers, including PC. The purpose of this review is to provide an overview of previous published studies on circulating miRNAs in plasma/serum for early detection of PC and summarize their diagnostic value. PubMed, Embase and Web of Science were systematically searched for eligible studies on circulating miRNAs for PC detection. Overall, 29 studies published between 2009 and 2018 evaluating 51 individual miRNAs (no P-value exceeding 0.05) and 13 miRNAs panels were included. Generally, the diagnostic performance of circulating miRNAs for PC detection was strong, with both the sensitivity and specificity of 36% individual miRNAs and 40% miRNAs panels exceeding 80%. Moreover, two promising miRNA panels were discovered and verified externally with all AUC values exceeding 0.95. Therefore, circulating miRNAs may hold potential to be used as noninvasive diagnostic biomarkers for PC, but large-scale studies are still needed to validate the promising miRNAs and optimize the miRNA panels. Since, the tremendous heterogeneity of studies in this field hampers translating miRNA markers into clinical practice, miRNA analytical procedures are also needed to be standardized in the future.Keywords: pancreatic cancer, early detection, circulating microRNAs Ausführliche Beschreibung

Gespeichert in:

Autor*in:	Xue J [verfasserIn] Jia E [verfasserIn] Ren N [verfasserIn] Lindsay A [verfasserIn] Yu H [verfasserIn]

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2019

Schlagwörter:	pancreatic cancer early detection circulating microRNAs

Übergeordnetes Werk:	In: OncoTargets and Therapy - Dove Medical Press, 2009, (2019), Seite 6665-6684
Übergeordnetes Werk:	year:2019 ; pages:6665-6684

Links:	Link aufrufen Link aufrufen Journal toc

Katalog-ID:	DOAJ019988745

Internformat


LEADER	01000caa a22002652 4500
001	DOAJ019988745
003	DE-627
005	20230307034030.0
007	cr uuu---uuuuu
008	230226s2019 xx \|\|\|\|\|o 00\| \|\|eng c
035			\|a (DE-627)DOAJ019988745
035			\|a (DE-599)DOAJ09fc63e11e5e48aa84c31c4d91a6abcd
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
050		0	\|a RC254-282
100	0		\|a Xue J \|e verfasserin \|4 aut
245	1	0	\|a Circulating microRNAs as promising diagnostic biomarkers for pancreatic cancer: a systematic review
264		1	\|c 2019
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
520			\|a Jinru Xue,1,* Erna Jia,2,* Na Ren,1 Andrew Lindsay,3,4 Haixin Yu1,51Department of Thoracic Surgery, China-Japan Union Hospital of Jilin University, Changchun, People’s Republic of China; 2Department of Gastroenterology, China-Japan Union Hospital of Jilin University, Changchun, People’s Republic of China; 3Major Cancer Biology, German Cancer Research Center, Heidelberg, Germany; 4Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany; 5Medical Faculty Heidelberg, University of Heidelberg, Heidelberg, GermanyCorrespondence: Haixin YuDepartment of Thoracic Surgery, China-Japan Union Hospital of Jilin University, No. 126, Xiantai Avenue, Changchun 130033, People’s Republic of ChinaTel +86 1 507 232 4782Fax +86 4 318 499 5852Email 534266311qq.com*These authors contributed equally to this workAbstract: Pancreatic cancer (PC) is one of the most common forms of malignant tumors and causes of tumor-related death worldwide. The current prognosis of PC still remains poor due to the lack of effective early detection method. Recently, there is strong support that circulating miRNAs can be used as biomarkers for early detection of various cancers, including PC. The purpose of this review is to provide an overview of previous published studies on circulating miRNAs in plasma/serum for early detection of PC and summarize their diagnostic value. PubMed, Embase and Web of Science were systematically searched for eligible studies on circulating miRNAs for PC detection. Overall, 29 studies published between 2009 and 2018 evaluating 51 individual miRNAs (no P-value exceeding 0.05) and 13 miRNAs panels were included. Generally, the diagnostic performance of circulating miRNAs for PC detection was strong, with both the sensitivity and specificity of 36% individual miRNAs and 40% miRNAs panels exceeding 80%. Moreover, two promising miRNA panels were discovered and verified externally with all AUC values exceeding 0.95. Therefore, circulating miRNAs may hold potential to be used as noninvasive diagnostic biomarkers for PC, but large-scale studies are still needed to validate the promising miRNAs and optimize the miRNA panels. Since, the tremendous heterogeneity of studies in this field hampers translating miRNA markers into clinical practice, miRNA analytical procedures are also needed to be standardized in the future.Keywords: pancreatic cancer, early detection, circulating microRNAs
650		4	\|a pancreatic cancer
650		4	\|a early detection
650		4	\|a circulating microRNAs
653		0	\|a Neoplasms. Tumors. Oncology. Including cancer and carcinogens
700	0		\|a Jia E \|e verfasserin \|4 aut
700	0		\|a Ren N \|e verfasserin \|4 aut
700	0		\|a Lindsay A \|e verfasserin \|4 aut
700	0		\|a Yu H \|e verfasserin \|4 aut
773	0	8	\|i In \|t OncoTargets and Therapy \|d Dove Medical Press, 2009 \|g (2019), Seite 6665-6684 \|w (DE-627)600307654 \|w (DE-600)2495130-4 \|x 11786930 \|7 nnns
773	1	8	\|g year:2019 \|g pages:6665-6684
856	4	0	\|u https://doaj.org/article/09fc63e11e5e48aa84c31c4d91a6abcd \|z kostenfrei
856	4	0	\|u https://www.dovepress.com/circulating-micrornas-as-promising-diagnostic-biomarkers-for-pancreati-peer-reviewed-article-OTT \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/1178-6930 \|y Journal toc \|z kostenfrei
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_DOAJ
912			\|a GBV_ILN_11
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_95
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_151
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_206
912			\|a GBV_ILN_213
912			\|a GBV_ILN_230
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_602
912			\|a GBV_ILN_2003
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2011
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_2055
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4367
912			\|a GBV_ILN_4700
951			\|a AR
952			\|j 2019 \|h 6665-6684

Indexfelder

author_variant	x j xj j e je r n rn l a la y h yh
matchkey_str	article:11786930:2019----::icltnmconssrmsndansiboakrfracet
hierarchy_sort_str	2019
callnumber-subject-code	RC
publishDate	2019
allfields	(DE-627)DOAJ019988745 (DE-599)DOAJ09fc63e11e5e48aa84c31c4d91a6abcd DE-627 ger DE-627 rakwb eng RC254-282 Xue J verfasserin aut Circulating microRNAs as promising diagnostic biomarkers for pancreatic cancer: a systematic review 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Jinru Xue,1,* Erna Jia,2,* Na Ren,1 Andrew Lindsay,3,4 Haixin Yu1,51Department of Thoracic Surgery, China-Japan Union Hospital of Jilin University, Changchun, People’s Republic of China; 2Department of Gastroenterology, China-Japan Union Hospital of Jilin University, Changchun, People’s Republic of China; 3Major Cancer Biology, German Cancer Research Center, Heidelberg, Germany; 4Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany; 5Medical Faculty Heidelberg, University of Heidelberg, Heidelberg, GermanyCorrespondence: Haixin YuDepartment of Thoracic Surgery, China-Japan Union Hospital of Jilin University, No. 126, Xiantai Avenue, Changchun 130033, People’s Republic of ChinaTel +86 1 507 232 4782Fax +86 4 318 499 5852Email 534266311qq.com*These authors contributed equally to this workAbstract: Pancreatic cancer (PC) is one of the most common forms of malignant tumors and causes of tumor-related death worldwide. The current prognosis of PC still remains poor due to the lack of effective early detection method. Recently, there is strong support that circulating miRNAs can be used as biomarkers for early detection of various cancers, including PC. The purpose of this review is to provide an overview of previous published studies on circulating miRNAs in plasma/serum for early detection of PC and summarize their diagnostic value. PubMed, Embase and Web of Science were systematically searched for eligible studies on circulating miRNAs for PC detection. Overall, 29 studies published between 2009 and 2018 evaluating 51 individual miRNAs (no P-value exceeding 0.05) and 13 miRNAs panels were included. Generally, the diagnostic performance of circulating miRNAs for PC detection was strong, with both the sensitivity and specificity of 36% individual miRNAs and 40% miRNAs panels exceeding 80%. Moreover, two promising miRNA panels were discovered and verified externally with all AUC values exceeding 0.95. Therefore, circulating miRNAs may hold potential to be used as noninvasive diagnostic biomarkers for PC, but large-scale studies are still needed to validate the promising miRNAs and optimize the miRNA panels. Since, the tremendous heterogeneity of studies in this field hampers translating miRNA markers into clinical practice, miRNA analytical procedures are also needed to be standardized in the future.Keywords: pancreatic cancer, early detection, circulating microRNAs pancreatic cancer early detection circulating microRNAs Neoplasms. Tumors. Oncology. Including cancer and carcinogens Jia E verfasserin aut Ren N verfasserin aut Lindsay A verfasserin aut Yu H verfasserin aut In OncoTargets and Therapy Dove Medical Press, 2009 (2019), Seite 6665-6684 (DE-627)600307654 (DE-600)2495130-4 11786930 nnns year:2019 pages:6665-6684 https://doaj.org/article/09fc63e11e5e48aa84c31c4d91a6abcd kostenfrei https://www.dovepress.com/circulating-micrornas-as-promising-diagnostic-biomarkers-for-pancreati-peer-reviewed-article-OTT kostenfrei https://doaj.org/toc/1178-6930 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2019 6665-6684
spelling	(DE-627)DOAJ019988745 (DE-599)DOAJ09fc63e11e5e48aa84c31c4d91a6abcd DE-627 ger DE-627 rakwb eng RC254-282 Xue J verfasserin aut Circulating microRNAs as promising diagnostic biomarkers for pancreatic cancer: a systematic review 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Jinru Xue,1,* Erna Jia,2,* Na Ren,1 Andrew Lindsay,3,4 Haixin Yu1,51Department of Thoracic Surgery, China-Japan Union Hospital of Jilin University, Changchun, People’s Republic of China; 2Department of Gastroenterology, China-Japan Union Hospital of Jilin University, Changchun, People’s Republic of China; 3Major Cancer Biology, German Cancer Research Center, Heidelberg, Germany; 4Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany; 5Medical Faculty Heidelberg, University of Heidelberg, Heidelberg, GermanyCorrespondence: Haixin YuDepartment of Thoracic Surgery, China-Japan Union Hospital of Jilin University, No. 126, Xiantai Avenue, Changchun 130033, People’s Republic of ChinaTel +86 1 507 232 4782Fax +86 4 318 499 5852Email 534266311qq.com*These authors contributed equally to this workAbstract: Pancreatic cancer (PC) is one of the most common forms of malignant tumors and causes of tumor-related death worldwide. The current prognosis of PC still remains poor due to the lack of effective early detection method. Recently, there is strong support that circulating miRNAs can be used as biomarkers for early detection of various cancers, including PC. The purpose of this review is to provide an overview of previous published studies on circulating miRNAs in plasma/serum for early detection of PC and summarize their diagnostic value. PubMed, Embase and Web of Science were systematically searched for eligible studies on circulating miRNAs for PC detection. Overall, 29 studies published between 2009 and 2018 evaluating 51 individual miRNAs (no P-value exceeding 0.05) and 13 miRNAs panels were included. Generally, the diagnostic performance of circulating miRNAs for PC detection was strong, with both the sensitivity and specificity of 36% individual miRNAs and 40% miRNAs panels exceeding 80%. Moreover, two promising miRNA panels were discovered and verified externally with all AUC values exceeding 0.95. Therefore, circulating miRNAs may hold potential to be used as noninvasive diagnostic biomarkers for PC, but large-scale studies are still needed to validate the promising miRNAs and optimize the miRNA panels. Since, the tremendous heterogeneity of studies in this field hampers translating miRNA markers into clinical practice, miRNA analytical procedures are also needed to be standardized in the future.Keywords: pancreatic cancer, early detection, circulating microRNAs pancreatic cancer early detection circulating microRNAs Neoplasms. Tumors. Oncology. Including cancer and carcinogens Jia E verfasserin aut Ren N verfasserin aut Lindsay A verfasserin aut Yu H verfasserin aut In OncoTargets and Therapy Dove Medical Press, 2009 (2019), Seite 6665-6684 (DE-627)600307654 (DE-600)2495130-4 11786930 nnns year:2019 pages:6665-6684 https://doaj.org/article/09fc63e11e5e48aa84c31c4d91a6abcd kostenfrei https://www.dovepress.com/circulating-micrornas-as-promising-diagnostic-biomarkers-for-pancreati-peer-reviewed-article-OTT kostenfrei https://doaj.org/toc/1178-6930 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2019 6665-6684
allfields_unstemmed	(DE-627)DOAJ019988745 (DE-599)DOAJ09fc63e11e5e48aa84c31c4d91a6abcd DE-627 ger DE-627 rakwb eng RC254-282 Xue J verfasserin aut Circulating microRNAs as promising diagnostic biomarkers for pancreatic cancer: a systematic review 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Jinru Xue,1,* Erna Jia,2,* Na Ren,1 Andrew Lindsay,3,4 Haixin Yu1,51Department of Thoracic Surgery, China-Japan Union Hospital of Jilin University, Changchun, People’s Republic of China; 2Department of Gastroenterology, China-Japan Union Hospital of Jilin University, Changchun, People’s Republic of China; 3Major Cancer Biology, German Cancer Research Center, Heidelberg, Germany; 4Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany; 5Medical Faculty Heidelberg, University of Heidelberg, Heidelberg, GermanyCorrespondence: Haixin YuDepartment of Thoracic Surgery, China-Japan Union Hospital of Jilin University, No. 126, Xiantai Avenue, Changchun 130033, People’s Republic of ChinaTel +86 1 507 232 4782Fax +86 4 318 499 5852Email 534266311qq.com*These authors contributed equally to this workAbstract: Pancreatic cancer (PC) is one of the most common forms of malignant tumors and causes of tumor-related death worldwide. The current prognosis of PC still remains poor due to the lack of effective early detection method. Recently, there is strong support that circulating miRNAs can be used as biomarkers for early detection of various cancers, including PC. The purpose of this review is to provide an overview of previous published studies on circulating miRNAs in plasma/serum for early detection of PC and summarize their diagnostic value. PubMed, Embase and Web of Science were systematically searched for eligible studies on circulating miRNAs for PC detection. Overall, 29 studies published between 2009 and 2018 evaluating 51 individual miRNAs (no P-value exceeding 0.05) and 13 miRNAs panels were included. Generally, the diagnostic performance of circulating miRNAs for PC detection was strong, with both the sensitivity and specificity of 36% individual miRNAs and 40% miRNAs panels exceeding 80%. Moreover, two promising miRNA panels were discovered and verified externally with all AUC values exceeding 0.95. Therefore, circulating miRNAs may hold potential to be used as noninvasive diagnostic biomarkers for PC, but large-scale studies are still needed to validate the promising miRNAs and optimize the miRNA panels. Since, the tremendous heterogeneity of studies in this field hampers translating miRNA markers into clinical practice, miRNA analytical procedures are also needed to be standardized in the future.Keywords: pancreatic cancer, early detection, circulating microRNAs pancreatic cancer early detection circulating microRNAs Neoplasms. Tumors. Oncology. Including cancer and carcinogens Jia E verfasserin aut Ren N verfasserin aut Lindsay A verfasserin aut Yu H verfasserin aut In OncoTargets and Therapy Dove Medical Press, 2009 (2019), Seite 6665-6684 (DE-627)600307654 (DE-600)2495130-4 11786930 nnns year:2019 pages:6665-6684 https://doaj.org/article/09fc63e11e5e48aa84c31c4d91a6abcd kostenfrei https://www.dovepress.com/circulating-micrornas-as-promising-diagnostic-biomarkers-for-pancreati-peer-reviewed-article-OTT kostenfrei https://doaj.org/toc/1178-6930 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2019 6665-6684
allfieldsGer	(DE-627)DOAJ019988745 (DE-599)DOAJ09fc63e11e5e48aa84c31c4d91a6abcd DE-627 ger DE-627 rakwb eng RC254-282 Xue J verfasserin aut Circulating microRNAs as promising diagnostic biomarkers for pancreatic cancer: a systematic review 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Jinru Xue,1,* Erna Jia,2,* Na Ren,1 Andrew Lindsay,3,4 Haixin Yu1,51Department of Thoracic Surgery, China-Japan Union Hospital of Jilin University, Changchun, People’s Republic of China; 2Department of Gastroenterology, China-Japan Union Hospital of Jilin University, Changchun, People’s Republic of China; 3Major Cancer Biology, German Cancer Research Center, Heidelberg, Germany; 4Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany; 5Medical Faculty Heidelberg, University of Heidelberg, Heidelberg, GermanyCorrespondence: Haixin YuDepartment of Thoracic Surgery, China-Japan Union Hospital of Jilin University, No. 126, Xiantai Avenue, Changchun 130033, People’s Republic of ChinaTel +86 1 507 232 4782Fax +86 4 318 499 5852Email 534266311qq.com*These authors contributed equally to this workAbstract: Pancreatic cancer (PC) is one of the most common forms of malignant tumors and causes of tumor-related death worldwide. The current prognosis of PC still remains poor due to the lack of effective early detection method. Recently, there is strong support that circulating miRNAs can be used as biomarkers for early detection of various cancers, including PC. The purpose of this review is to provide an overview of previous published studies on circulating miRNAs in plasma/serum for early detection of PC and summarize their diagnostic value. PubMed, Embase and Web of Science were systematically searched for eligible studies on circulating miRNAs for PC detection. Overall, 29 studies published between 2009 and 2018 evaluating 51 individual miRNAs (no P-value exceeding 0.05) and 13 miRNAs panels were included. Generally, the diagnostic performance of circulating miRNAs for PC detection was strong, with both the sensitivity and specificity of 36% individual miRNAs and 40% miRNAs panels exceeding 80%. Moreover, two promising miRNA panels were discovered and verified externally with all AUC values exceeding 0.95. Therefore, circulating miRNAs may hold potential to be used as noninvasive diagnostic biomarkers for PC, but large-scale studies are still needed to validate the promising miRNAs and optimize the miRNA panels. Since, the tremendous heterogeneity of studies in this field hampers translating miRNA markers into clinical practice, miRNA analytical procedures are also needed to be standardized in the future.Keywords: pancreatic cancer, early detection, circulating microRNAs pancreatic cancer early detection circulating microRNAs Neoplasms. Tumors. Oncology. Including cancer and carcinogens Jia E verfasserin aut Ren N verfasserin aut Lindsay A verfasserin aut Yu H verfasserin aut In OncoTargets and Therapy Dove Medical Press, 2009 (2019), Seite 6665-6684 (DE-627)600307654 (DE-600)2495130-4 11786930 nnns year:2019 pages:6665-6684 https://doaj.org/article/09fc63e11e5e48aa84c31c4d91a6abcd kostenfrei https://www.dovepress.com/circulating-micrornas-as-promising-diagnostic-biomarkers-for-pancreati-peer-reviewed-article-OTT kostenfrei https://doaj.org/toc/1178-6930 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2019 6665-6684
allfieldsSound	(DE-627)DOAJ019988745 (DE-599)DOAJ09fc63e11e5e48aa84c31c4d91a6abcd DE-627 ger DE-627 rakwb eng RC254-282 Xue J verfasserin aut Circulating microRNAs as promising diagnostic biomarkers for pancreatic cancer: a systematic review 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Jinru Xue,1,* Erna Jia,2,* Na Ren,1 Andrew Lindsay,3,4 Haixin Yu1,51Department of Thoracic Surgery, China-Japan Union Hospital of Jilin University, Changchun, People’s Republic of China; 2Department of Gastroenterology, China-Japan Union Hospital of Jilin University, Changchun, People’s Republic of China; 3Major Cancer Biology, German Cancer Research Center, Heidelberg, Germany; 4Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany; 5Medical Faculty Heidelberg, University of Heidelberg, Heidelberg, GermanyCorrespondence: Haixin YuDepartment of Thoracic Surgery, China-Japan Union Hospital of Jilin University, No. 126, Xiantai Avenue, Changchun 130033, People’s Republic of ChinaTel +86 1 507 232 4782Fax +86 4 318 499 5852Email 534266311qq.com*These authors contributed equally to this workAbstract: Pancreatic cancer (PC) is one of the most common forms of malignant tumors and causes of tumor-related death worldwide. The current prognosis of PC still remains poor due to the lack of effective early detection method. Recently, there is strong support that circulating miRNAs can be used as biomarkers for early detection of various cancers, including PC. The purpose of this review is to provide an overview of previous published studies on circulating miRNAs in plasma/serum for early detection of PC and summarize their diagnostic value. PubMed, Embase and Web of Science were systematically searched for eligible studies on circulating miRNAs for PC detection. Overall, 29 studies published between 2009 and 2018 evaluating 51 individual miRNAs (no P-value exceeding 0.05) and 13 miRNAs panels were included. Generally, the diagnostic performance of circulating miRNAs for PC detection was strong, with both the sensitivity and specificity of 36% individual miRNAs and 40% miRNAs panels exceeding 80%. Moreover, two promising miRNA panels were discovered and verified externally with all AUC values exceeding 0.95. Therefore, circulating miRNAs may hold potential to be used as noninvasive diagnostic biomarkers for PC, but large-scale studies are still needed to validate the promising miRNAs and optimize the miRNA panels. Since, the tremendous heterogeneity of studies in this field hampers translating miRNA markers into clinical practice, miRNA analytical procedures are also needed to be standardized in the future.Keywords: pancreatic cancer, early detection, circulating microRNAs pancreatic cancer early detection circulating microRNAs Neoplasms. Tumors. Oncology. Including cancer and carcinogens Jia E verfasserin aut Ren N verfasserin aut Lindsay A verfasserin aut Yu H verfasserin aut In OncoTargets and Therapy Dove Medical Press, 2009 (2019), Seite 6665-6684 (DE-627)600307654 (DE-600)2495130-4 11786930 nnns year:2019 pages:6665-6684 https://doaj.org/article/09fc63e11e5e48aa84c31c4d91a6abcd kostenfrei https://www.dovepress.com/circulating-micrornas-as-promising-diagnostic-biomarkers-for-pancreati-peer-reviewed-article-OTT kostenfrei https://doaj.org/toc/1178-6930 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2019 6665-6684
language	English
source	In OncoTargets and Therapy (2019), Seite 6665-6684 year:2019 pages:6665-6684
sourceStr	In OncoTargets and Therapy (2019), Seite 6665-6684 year:2019 pages:6665-6684
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	pancreatic cancer early detection circulating microRNAs Neoplasms. Tumors. Oncology. Including cancer and carcinogens
isfreeaccess_bool	true
container_title	OncoTargets and Therapy
authorswithroles_txt_mv	Xue J @@aut@@ Jia E @@aut@@ Ren N @@aut@@ Lindsay A @@aut@@ Yu H @@aut@@
publishDateDaySort_date	2019-01-01T00:00:00Z
hierarchy_top_id	600307654
id	DOAJ019988745
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ019988745</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230307034030.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2019 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ019988745</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ09fc63e11e5e48aa84c31c4d91a6abcd</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC254-282</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Xue J</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Circulating microRNAs as promising diagnostic biomarkers for pancreatic cancer: a systematic review</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Jinru Xue,1,* Erna Jia,2,* Na Ren,1 Andrew Lindsay,3,4 Haixin Yu1,51Department of Thoracic Surgery, China-Japan Union Hospital of Jilin University, Changchun, People&rsquo;s Republic of China; 2Department of Gastroenterology, China-Japan Union Hospital of Jilin University, Changchun, People&rsquo;s Republic of China; 3Major Cancer Biology, German Cancer Research Center, Heidelberg, Germany; 4Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany; 5Medical Faculty Heidelberg, University of Heidelberg, Heidelberg, GermanyCorrespondence: Haixin YuDepartment of Thoracic Surgery, China-Japan Union Hospital of Jilin University, No. 126, Xiantai Avenue, Changchun 130033, People&rsquo;s Republic of ChinaTel +86 1 507 232 4782Fax +86 4 318 499 5852Email 534266311qq.com*These authors contributed equally to this workAbstract: Pancreatic cancer (PC) is one of the most common forms of malignant tumors and causes of tumor-related death worldwide. The current prognosis of PC still remains poor due to the lack of effective early detection method. Recently, there is strong support that circulating miRNAs can be used as biomarkers for early detection of various cancers, including PC. The purpose of this review is to provide an overview of previous published studies on circulating miRNAs in plasma/serum for early detection of PC and summarize their diagnostic value. PubMed, Embase and Web of Science were systematically searched for eligible studies on circulating miRNAs for PC detection. Overall, 29 studies published between 2009 and 2018 evaluating 51 individual miRNAs (no P-value exceeding 0.05) and 13 miRNAs panels were included. Generally, the diagnostic performance of circulating miRNAs for PC detection was strong, with both the sensitivity and specificity of 36% individual miRNAs and 40% miRNAs panels exceeding 80%. Moreover, two promising miRNA panels were discovered and verified externally with all AUC values exceeding 0.95. Therefore, circulating miRNAs may hold potential to be used as noninvasive diagnostic biomarkers for PC, but large-scale studies are still needed to validate the promising miRNAs and optimize the miRNA panels. Since, the tremendous heterogeneity of studies in this field hampers translating miRNA markers into clinical practice, miRNA analytical procedures are also needed to be standardized in the future.Keywords: pancreatic cancer, early detection, circulating microRNAs</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">pancreatic cancer</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">early detection</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">circulating microRNAs</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Neoplasms. Tumors. Oncology. Including cancer and carcinogens</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jia E</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ren N</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Lindsay A</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yu H</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">OncoTargets and Therapy</subfield><subfield code="d">Dove Medical Press, 2009</subfield><subfield code="g">(2019), Seite 6665-6684</subfield><subfield code="w">(DE-627)600307654</subfield><subfield code="w">(DE-600)2495130-4</subfield><subfield code="x">11786930</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">year:2019</subfield><subfield code="g">pages:6665-6684</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/09fc63e11e5e48aa84c31c4d91a6abcd</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.dovepress.com/circulating-micrornas-as-promising-diagnostic-biomarkers-for-pancreati-peer-reviewed-article-OTT</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1178-6930</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="j">2019</subfield><subfield code="h">6665-6684</subfield></datafield></record></collection>
callnumber-first	R - Medicine
author	Xue J
spellingShingle	Xue J misc RC254-282 misc pancreatic cancer misc early detection misc circulating microRNAs misc Neoplasms. Tumors. Oncology. Including cancer and carcinogens Circulating microRNAs as promising diagnostic biomarkers for pancreatic cancer: a systematic review
authorStr	Xue J
ppnlink_with_tag_str_mv	@@773@@(DE-627)600307654
format	electronic Article
delete_txt_mv	keep
author_role	aut aut aut aut aut
collection	DOAJ
remote_str	true
callnumber-label	RC254-282
illustrated	Not Illustrated
issn	11786930
topic_title	RC254-282 Circulating microRNAs as promising diagnostic biomarkers for pancreatic cancer: a systematic review pancreatic cancer early detection circulating microRNAs
topic	misc RC254-282 misc pancreatic cancer misc early detection misc circulating microRNAs misc Neoplasms. Tumors. Oncology. Including cancer and carcinogens
topic_unstemmed	misc RC254-282 misc pancreatic cancer misc early detection misc circulating microRNAs misc Neoplasms. Tumors. Oncology. Including cancer and carcinogens
topic_browse	misc RC254-282 misc pancreatic cancer misc early detection misc circulating microRNAs misc Neoplasms. Tumors. Oncology. Including cancer and carcinogens
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	OncoTargets and Therapy
hierarchy_parent_id	600307654
hierarchy_top_title	OncoTargets and Therapy
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)600307654 (DE-600)2495130-4
title	Circulating microRNAs as promising diagnostic biomarkers for pancreatic cancer: a systematic review
ctrlnum	(DE-627)DOAJ019988745 (DE-599)DOAJ09fc63e11e5e48aa84c31c4d91a6abcd
title_full	Circulating microRNAs as promising diagnostic biomarkers for pancreatic cancer: a systematic review
author_sort	Xue J
journal	OncoTargets and Therapy
journalStr	OncoTargets and Therapy
callnumber-first-code	R
lang_code	eng
isOA_bool	true
recordtype	marc
publishDateSort	2019
contenttype_str_mv	txt
container_start_page	6665
author_browse	Xue J Jia E Ren N Lindsay A Yu H
class	RC254-282
format_se	Elektronische Aufsätze
author-letter	Xue J
author2-role	verfasserin
title_sort	circulating micrornas as promising diagnostic biomarkers for pancreatic cancer: a systematic review
callnumber	RC254-282
title_auth	Circulating microRNAs as promising diagnostic biomarkers for pancreatic cancer: a systematic review
abstract	Jinru Xue,1,* Erna Jia,2,* Na Ren,1 Andrew Lindsay,3,4 Haixin Yu1,51Department of Thoracic Surgery, China-Japan Union Hospital of Jilin University, Changchun, People’s Republic of China; 2Department of Gastroenterology, China-Japan Union Hospital of Jilin University, Changchun, People’s Republic of China; 3Major Cancer Biology, German Cancer Research Center, Heidelberg, Germany; 4Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany; 5Medical Faculty Heidelberg, University of Heidelberg, Heidelberg, GermanyCorrespondence: Haixin YuDepartment of Thoracic Surgery, China-Japan Union Hospital of Jilin University, No. 126, Xiantai Avenue, Changchun 130033, People’s Republic of ChinaTel +86 1 507 232 4782Fax +86 4 318 499 5852Email 534266311qq.com*These authors contributed equally to this workAbstract: Pancreatic cancer (PC) is one of the most common forms of malignant tumors and causes of tumor-related death worldwide. The current prognosis of PC still remains poor due to the lack of effective early detection method. Recently, there is strong support that circulating miRNAs can be used as biomarkers for early detection of various cancers, including PC. The purpose of this review is to provide an overview of previous published studies on circulating miRNAs in plasma/serum for early detection of PC and summarize their diagnostic value. PubMed, Embase and Web of Science were systematically searched for eligible studies on circulating miRNAs for PC detection. Overall, 29 studies published between 2009 and 2018 evaluating 51 individual miRNAs (no P-value exceeding 0.05) and 13 miRNAs panels were included. Generally, the diagnostic performance of circulating miRNAs for PC detection was strong, with both the sensitivity and specificity of 36% individual miRNAs and 40% miRNAs panels exceeding 80%. Moreover, two promising miRNA panels were discovered and verified externally with all AUC values exceeding 0.95. Therefore, circulating miRNAs may hold potential to be used as noninvasive diagnostic biomarkers for PC, but large-scale studies are still needed to validate the promising miRNAs and optimize the miRNA panels. Since, the tremendous heterogeneity of studies in this field hampers translating miRNA markers into clinical practice, miRNA analytical procedures are also needed to be standardized in the future.Keywords: pancreatic cancer, early detection, circulating microRNAs
abstractGer	Jinru Xue,1,* Erna Jia,2,* Na Ren,1 Andrew Lindsay,3,4 Haixin Yu1,51Department of Thoracic Surgery, China-Japan Union Hospital of Jilin University, Changchun, People’s Republic of China; 2Department of Gastroenterology, China-Japan Union Hospital of Jilin University, Changchun, People’s Republic of China; 3Major Cancer Biology, German Cancer Research Center, Heidelberg, Germany; 4Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany; 5Medical Faculty Heidelberg, University of Heidelberg, Heidelberg, GermanyCorrespondence: Haixin YuDepartment of Thoracic Surgery, China-Japan Union Hospital of Jilin University, No. 126, Xiantai Avenue, Changchun 130033, People’s Republic of ChinaTel +86 1 507 232 4782Fax +86 4 318 499 5852Email 534266311qq.com*These authors contributed equally to this workAbstract: Pancreatic cancer (PC) is one of the most common forms of malignant tumors and causes of tumor-related death worldwide. The current prognosis of PC still remains poor due to the lack of effective early detection method. Recently, there is strong support that circulating miRNAs can be used as biomarkers for early detection of various cancers, including PC. The purpose of this review is to provide an overview of previous published studies on circulating miRNAs in plasma/serum for early detection of PC and summarize their diagnostic value. PubMed, Embase and Web of Science were systematically searched for eligible studies on circulating miRNAs for PC detection. Overall, 29 studies published between 2009 and 2018 evaluating 51 individual miRNAs (no P-value exceeding 0.05) and 13 miRNAs panels were included. Generally, the diagnostic performance of circulating miRNAs for PC detection was strong, with both the sensitivity and specificity of 36% individual miRNAs and 40% miRNAs panels exceeding 80%. Moreover, two promising miRNA panels were discovered and verified externally with all AUC values exceeding 0.95. Therefore, circulating miRNAs may hold potential to be used as noninvasive diagnostic biomarkers for PC, but large-scale studies are still needed to validate the promising miRNAs and optimize the miRNA panels. Since, the tremendous heterogeneity of studies in this field hampers translating miRNA markers into clinical practice, miRNA analytical procedures are also needed to be standardized in the future.Keywords: pancreatic cancer, early detection, circulating microRNAs
abstract_unstemmed	Jinru Xue,1,* Erna Jia,2,* Na Ren,1 Andrew Lindsay,3,4 Haixin Yu1,51Department of Thoracic Surgery, China-Japan Union Hospital of Jilin University, Changchun, People’s Republic of China; 2Department of Gastroenterology, China-Japan Union Hospital of Jilin University, Changchun, People’s Republic of China; 3Major Cancer Biology, German Cancer Research Center, Heidelberg, Germany; 4Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany; 5Medical Faculty Heidelberg, University of Heidelberg, Heidelberg, GermanyCorrespondence: Haixin YuDepartment of Thoracic Surgery, China-Japan Union Hospital of Jilin University, No. 126, Xiantai Avenue, Changchun 130033, People’s Republic of ChinaTel +86 1 507 232 4782Fax +86 4 318 499 5852Email 534266311qq.com*These authors contributed equally to this workAbstract: Pancreatic cancer (PC) is one of the most common forms of malignant tumors and causes of tumor-related death worldwide. The current prognosis of PC still remains poor due to the lack of effective early detection method. Recently, there is strong support that circulating miRNAs can be used as biomarkers for early detection of various cancers, including PC. The purpose of this review is to provide an overview of previous published studies on circulating miRNAs in plasma/serum for early detection of PC and summarize their diagnostic value. PubMed, Embase and Web of Science were systematically searched for eligible studies on circulating miRNAs for PC detection. Overall, 29 studies published between 2009 and 2018 evaluating 51 individual miRNAs (no P-value exceeding 0.05) and 13 miRNAs panels were included. Generally, the diagnostic performance of circulating miRNAs for PC detection was strong, with both the sensitivity and specificity of 36% individual miRNAs and 40% miRNAs panels exceeding 80%. Moreover, two promising miRNA panels were discovered and verified externally with all AUC values exceeding 0.95. Therefore, circulating miRNAs may hold potential to be used as noninvasive diagnostic biomarkers for PC, but large-scale studies are still needed to validate the promising miRNAs and optimize the miRNA panels. Since, the tremendous heterogeneity of studies in this field hampers translating miRNA markers into clinical practice, miRNA analytical procedures are also needed to be standardized in the future.Keywords: pancreatic cancer, early detection, circulating microRNAs
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700
title_short	Circulating microRNAs as promising diagnostic biomarkers for pancreatic cancer: a systematic review
url	https://doaj.org/article/09fc63e11e5e48aa84c31c4d91a6abcd https://www.dovepress.com/circulating-micrornas-as-promising-diagnostic-biomarkers-for-pancreati-peer-reviewed-article-OTT https://doaj.org/toc/1178-6930
remote_bool	true
author2	Jia E Ren N Lindsay A Yu H
author2Str	Jia E Ren N Lindsay A Yu H
ppnlink	600307654
callnumber-subject	RC - Internal Medicine
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
callnumber-a	RC254-282
up_date	2024-07-04T01:42:02.400Z
_version_	1803610826894999552
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ019988745</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230307034030.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2019 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ019988745</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ09fc63e11e5e48aa84c31c4d91a6abcd</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC254-282</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Xue J</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Circulating microRNAs as promising diagnostic biomarkers for pancreatic cancer: a systematic review</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Jinru Xue,1,* Erna Jia,2,* Na Ren,1 Andrew Lindsay,3,4 Haixin Yu1,51Department of Thoracic Surgery, China-Japan Union Hospital of Jilin University, Changchun, People&rsquo;s Republic of China; 2Department of Gastroenterology, China-Japan Union Hospital of Jilin University, Changchun, People&rsquo;s Republic of China; 3Major Cancer Biology, German Cancer Research Center, Heidelberg, Germany; 4Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany; 5Medical Faculty Heidelberg, University of Heidelberg, Heidelberg, GermanyCorrespondence: Haixin YuDepartment of Thoracic Surgery, China-Japan Union Hospital of Jilin University, No. 126, Xiantai Avenue, Changchun 130033, People&rsquo;s Republic of ChinaTel +86 1 507 232 4782Fax +86 4 318 499 5852Email 534266311qq.com*These authors contributed equally to this workAbstract: Pancreatic cancer (PC) is one of the most common forms of malignant tumors and causes of tumor-related death worldwide. The current prognosis of PC still remains poor due to the lack of effective early detection method. Recently, there is strong support that circulating miRNAs can be used as biomarkers for early detection of various cancers, including PC. The purpose of this review is to provide an overview of previous published studies on circulating miRNAs in plasma/serum for early detection of PC and summarize their diagnostic value. PubMed, Embase and Web of Science were systematically searched for eligible studies on circulating miRNAs for PC detection. Overall, 29 studies published between 2009 and 2018 evaluating 51 individual miRNAs (no P-value exceeding 0.05) and 13 miRNAs panels were included. Generally, the diagnostic performance of circulating miRNAs for PC detection was strong, with both the sensitivity and specificity of 36% individual miRNAs and 40% miRNAs panels exceeding 80%. Moreover, two promising miRNA panels were discovered and verified externally with all AUC values exceeding 0.95. Therefore, circulating miRNAs may hold potential to be used as noninvasive diagnostic biomarkers for PC, but large-scale studies are still needed to validate the promising miRNAs and optimize the miRNA panels. Since, the tremendous heterogeneity of studies in this field hampers translating miRNA markers into clinical practice, miRNA analytical procedures are also needed to be standardized in the future.Keywords: pancreatic cancer, early detection, circulating microRNAs</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">pancreatic cancer</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">early detection</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">circulating microRNAs</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Neoplasms. Tumors. Oncology. Including cancer and carcinogens</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jia E</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ren N</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Lindsay A</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yu H</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">OncoTargets and Therapy</subfield><subfield code="d">Dove Medical Press, 2009</subfield><subfield code="g">(2019), Seite 6665-6684</subfield><subfield code="w">(DE-627)600307654</subfield><subfield code="w">(DE-600)2495130-4</subfield><subfield code="x">11786930</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">year:2019</subfield><subfield code="g">pages:6665-6684</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/09fc63e11e5e48aa84c31c4d91a6abcd</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.dovepress.com/circulating-micrornas-as-promising-diagnostic-biomarkers-for-pancreati-peer-reviewed-article-OTT</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1178-6930</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="j">2019</subfield><subfield code="h">6665-6684</subfield></datafield></record></collection>
score	7.3997383

Nicht das Richtige dabei?

Schreiben Sie uns!

Circulating microRNAs as promising diagnostic biomarkers for pancreatic cancer: a systematic review

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?